Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04450329
Brief Title: A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)

First Submitted : June 24, 2020
First Submitted that Met QC Criteria : June 24, 2020
First Posted : June 29, 2020

Last Update Submitted that Met QC Criteria : April 29, 2021
Last Update Posted : May 3, 2021